Search This Blog

Monday, April 3, 2023

Innate Licenses Antibodies to Takeda for Celiac Disease Research

 

  • Takeda to obtain exclusive worldwide rights to develop, manufacture and commercialize Antibody Drug Conjugates (ADC) using a panel of selected antibodies developed by Innate

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)